EP3512863
2‘-setin-N6-setin púrín-kirni til meðhöndlunar á RNA-veiru
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
6.9.2017EP published:
8.12.2021EP application number:
17849474.6
EP translation filed:
3.2.2022Grant published:
15.3.2022EPO information:
European Patent Register
Max expiry date:
5.9.2037Expiry date:
5.9.2026Next due date:
30.9.2026
Title in English:
2'-SUBSTITUTED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR RNA VIRUS TREATMENTLanguage of the patent:
English
Timeline
Today
6.9.2017EP application
8.12.2021EP Publication
3.2.2022Translation submitted
15.3.2022Registration published
5.9.2026Expires
Owner
Name:
ATEA Pharmaceuticals, Inc.Address:
125 Summer Street, Boston, MA 02110, US
Inventor
Name:
SOMMADOSSI, Jean-PierreAddress:
Boston, MA 02110, US
Name:
MOUSSA, AdelAddress:
Boston, MA 02110, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662384664 PDate:
7.9.2016Country:
US
Classification
Categories:
A61K 31/675, A61K 31/7076, C07H 23/00, C07H 19/16, C07H 19/207, C07H 19/20, A61P 1/00, A61P 31/14
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 16.8.2022
Expires: 5.9.2023
Payer: Árnason Faktor ehf.
Number: 7
Paid: 5.9.2023
Expires: 5.9.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 7.8.2024
Expires: 5.9.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 9.9.2025
Expires: 5.9.2026
Payer: Árnason Faktor ehf.